NL190702B - 4h-pyrido(1,2-a)pyrimidin-4-on verbinding met anti-allergische werkzaamheid, alsmede farmaceutisch preparaat daarvan. - Google Patents

4h-pyrido(1,2-a)pyrimidin-4-on verbinding met anti-allergische werkzaamheid, alsmede farmaceutisch preparaat daarvan.

Info

Publication number
NL190702B
NL190702B NLAANVRAGE7805534,A NL7805534A NL190702B NL 190702 B NL190702 B NL 190702B NL 7805534 A NL7805534 A NL 7805534A NL 190702 B NL190702 B NL 190702B
Authority
NL
Netherlands
Prior art keywords
pyrido
pyrimidin
compound
pharmaceutical preparation
allergic effect
Prior art date
Application number
NLAANVRAGE7805534,A
Other languages
English (en)
Other versions
NL190702C (nl
NL7805534A (nl
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of NL7805534A publication Critical patent/NL7805534A/nl
Publication of NL190702B publication Critical patent/NL190702B/nl
Application granted granted Critical
Publication of NL190702C publication Critical patent/NL190702C/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/40—Acylated substituent nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
NL7805534A 1977-05-25 1978-05-22 4H-pyrido[1,2-a]pyrimidin-4-on verbinding met anti-allergische werkzaamheid, alsmede farmaceutisch preparaat daarvan. NL190702C (nl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/800,264 US4122274A (en) 1977-05-25 1977-05-25 3-Tetrazolo-5,6,7,8-substituted-pyrido[1,2-a]pyrimidin-4-ones

Publications (3)

Publication Number Publication Date
NL7805534A NL7805534A (nl) 1978-11-28
NL190702B true NL190702B (nl) 1994-02-01
NL190702C NL190702C (nl) 1994-07-01

Family

ID=25177928

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7805534A NL190702C (nl) 1977-05-25 1978-05-22 4H-pyrido[1,2-a]pyrimidin-4-on verbinding met anti-allergische werkzaamheid, alsmede farmaceutisch preparaat daarvan.

Country Status (26)

Country Link
US (1) US4122274A (nl)
JP (1) JPS6050197B2 (nl)
AT (1) AT365187B (nl)
AU (1) AU521211B2 (nl)
BE (1) BE867295A (nl)
CA (1) CA1098520A (nl)
CH (1) CH642656A5 (nl)
CY (1) CY1218A (nl)
DE (1) DE2822544A1 (nl)
DK (1) DK160279C (nl)
FI (1) FI64594C (nl)
FR (1) FR2401159A1 (nl)
GB (1) GB1596476A (nl)
GR (1) GR71887B (nl)
HK (1) HK25884A (nl)
IE (1) IE46849B1 (nl)
IT (1) IT1105040B (nl)
KE (1) KE3357A (nl)
LU (1) LU79694A1 (nl)
MY (1) MY8500305A (nl)
NL (1) NL190702C (nl)
NO (1) NO150361C (nl)
SE (1) SE437830B (nl)
SG (1) SG73383G (nl)
YU (2) YU42163B (nl)
ZA (1) ZA782816B (nl)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4495189A (en) * 1975-11-27 1985-01-22 Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara R.T. Condensed pyrimidines
HU173438B (hu) * 1975-11-27 1979-05-28 Chinoin Gyogyszer Es Vegyeszet Sposob poluchenija novykh proizvodnykh 4-okso-1,6,7,8-/tetragidro-4h-pirido/1,2/pirimidina s zaderzhivajuhhejj vozgoranie aktivnot'ju i protivosvertivajuhhem effektom
HU180439B (en) * 1977-12-29 1983-03-28 Chinoin Gyogyszer Es Vegyeszet Process for producing 9-amino-pyrido-square bracket-1,2-a-square bracket closed-pyrimidine derivatives
US4192944A (en) * 1978-04-03 1980-03-11 Bristol-Myers Company Optionally substituted 4-oxo-4H-pyrido[1,2-a]pyrimidine-3-N-(1H-tetrazol-4-yl)carboxamides and their use as antiallergy agents
US4491587A (en) * 1978-05-05 1985-01-01 Mead Johnson & Company Tetrazole derivatives
US4223031A (en) * 1978-05-05 1980-09-16 Mead Johnson & Company Azolopyrimidinones
US4282360A (en) * 1979-10-12 1981-08-04 Hoffmann-La Roche Inc. 7-Methylthio or methylsulfinyl-5-oxo-5H-thiazolo[2,3-b]quinazoline-2-carboxylic acid
US4419357A (en) * 1982-01-18 1983-12-06 The Dow Chemical Company 3-(1H-Tetrazol-5-yl)-4(3H)-quinazolinones
US4474953A (en) * 1982-09-09 1984-10-02 Riker Laboratories, Inc. Process and intermediates for the preparation of 3(1H-tetrazol-5-yl)-4H-pyrido[1,2-a]pyrimidin-4-ones
US4476130A (en) * 1982-09-09 1984-10-09 Riker Laboratories, Inc. 3-(1H-Tetrazol-5-yl)-4H-pyrimido[2,1-b]benzoxazol-4-one compounds exhibiting anti-allergic activity
US4507477A (en) * 1982-09-09 1985-03-26 Riker Laboratories, Inc. Process for tetrazolyl-pyrimidinone derivatives
US4457932A (en) * 1983-07-22 1984-07-03 Bristol-Myers Company Anti-ulcer agents
CA1283411C (en) * 1985-09-25 1991-04-23 Masami Doteuchi 9-(substituted thio)-4h-pyrido[1,2-a]-pyrimidin-4-one derivatives
JPS63183581A (ja) * 1985-10-03 1988-07-28 Tokyo Tanabe Co Ltd ピリド〔１，２−ａ〕ピリミジン誘導体、その製造法及びそれを有効成分とするアレルギ−疾患治療薬
JPS62242682A (ja) * 1986-04-16 1987-10-23 Tokyo Tanabe Co Ltd 新規なピリド［１，２―ａ］ピリミジン誘導体及びその製造法
JP2504788B2 (ja) * 1987-11-10 1996-06-05 東京田辺製薬株式会社 ９−メチル−３−（１Ｈ−テトラゾ―ル−５−イル）−４Ｈ−ピリド［１，２−ａ］ピリミジン−４−オンカリウム塩の水性製剤
AU610979B2 (en) * 1987-12-25 1991-05-30 Santen Pharmaceutical Co. Ltd. Antiallergic eye drop
CA2010336C (en) * 1989-02-27 1996-11-19 Atsunori Sano Process for producing pyrido[1,2-a]pyrimidine derivative
HU209793B (en) * 1990-09-25 1994-11-28 Chinoin Gyogyszer Es Vegyeszet Process for the production of pyrido[1,2-a]pyrimidine-derivatives and pharmaceutical compositions containing the same
EP0653209A4 (en) 1992-07-30 1997-03-19 Tokyo Tanabe Co MEDICINAL PRODUCTS FOR INFLAMMATORY COLON DISEASES.
US5527802A (en) * 1992-10-01 1996-06-18 Bristol-Myers Squibb Company New uses of 3-tetrazolo -5,6,7,8- substituted-pyrido (1,2-a) pyrimidin-4-ones
JPH0892093A (ja) * 1994-11-10 1996-04-09 Tokyo Tanabe Co Ltd ９−メチル−３−（１Ｈ−テトラゾール−５−イル）−４Ｈ−ピリド［１，２−ａ］ピリミジン−４−オンの水性製剤
KR100885007B1 (ko) * 2001-02-26 2009-02-20 미쓰비시 타나베 파마 코퍼레이션 신질환·신부전의 예방 또는 치료를 위한 약학 조성물
ITMI20011764A1 (it) * 2001-08-10 2003-02-10 Dinamite Dipharma Spa Metodo per l'ottenimento del pemirolast ad elevata purezza
GB0316546D0 (en) 2003-07-15 2003-08-20 Novartis Ag Process for the manufacture of organic compounds
PT2120919E (pt) * 2006-12-18 2012-11-12 Cardoz Ab Nova combinação para utilização no tratamento de perturbações inflamatórias
WO2008075028A1 (en) * 2006-12-20 2008-06-26 Cardoz Ab New combination for use in the treatment of inflammatory disorders
WO2009007675A2 (en) * 2007-07-11 2009-01-15 Cardoz Ab Combination for use in the treatment of atherosclerosis comprising a mast cell inhibitor and a p2 gamma 12 antagonist
AU2008273997A1 (en) * 2007-07-11 2009-01-15 Cardoz Ab Combination for use in the treatment of atherosclerosis comprising a mast cell inhibitor and a PPAR gamma agonist
WO2009007679A2 (en) * 2007-07-11 2009-01-15 Cardoz Ab Combination for use in the treatment of atherosclerosis comprising a mast cell inhibitor and a thromboxane a2 antagonist
US20110092463A1 (en) * 2008-04-07 2011-04-21 Johan Raud Combination for use in the treatment of inflammatory disorders
CN102596202B (zh) * 2009-06-16 2015-01-21 卡多兹公司 吡嘧司特的晶形
USD661900S1 (en) 2010-02-22 2012-06-19 Bajer Design & Marketing, Inc. Collapsible structure
EA037123B1 (ru) 2012-02-10 2021-02-09 ПиТиСи ТЕРАПЬЮТИКС, ИНК. Соединения для лечения спинальной мышечной атрофии
JP6092264B2 (ja) 2012-03-01 2017-03-08 ピーティーシー セラピューティクス， インコーポレイテッド 脊髄性筋委縮症を処置するための化合物
BR112014023483B1 (pt) 2012-03-23 2022-05-10 Ptc Therapeutics, Inc Composto e seu uso, composição farmacêutica e seu uso
WO2015105657A1 (en) 2013-12-19 2015-07-16 Ptc Therapeutics, Inc. Methods for modulating the amount of rna transcripts
WO2016063085A1 (en) 2014-10-23 2016-04-28 Rspr Pharma Ab Use of pemirolast in the treatment of acute asthma
WO2016102941A1 (en) 2014-12-22 2016-06-30 Rspr Pharma Ab New combination of pemirolast and montelukast
WO2016184832A1 (en) * 2015-05-20 2016-11-24 F. Hoffmann-La Roche Ag Compounds for treating spinal muscular atrophy
EP4249472A3 (en) 2015-05-30 2023-12-13 PTC Therapeutics, Inc. Methods for modulating rna splicing
GB201518831D0 (en) 2015-10-23 2015-12-09 Rspr Pharma Ab New use
AU2016366694C1 (en) 2015-12-10 2021-03-25 Ptc Therapeutics, Inc. Methods for treating huntington's disease
GB201601138D0 (en) * 2016-01-21 2016-03-09 Rspr Pharma Ab New use
AU2017363369A1 (en) 2016-11-28 2019-05-30 Ptc Therapeutics, Inc Methods for modulating RNA splicing
KR20200033249A (ko) 2017-06-05 2020-03-27 피티씨 테라퓨틱스, 인크. 헌팅턴병 치료 화합물
US11608501B2 (en) 2017-06-14 2023-03-21 Ptc Therapeutics, Inc. Methods for modifying RNA splicing
MX2019015580A (es) 2017-06-28 2020-07-28 Ptc Therapeutics Inc Metodos para tratar la enfermedad de huntington.
MX2019015578A (es) 2017-06-28 2020-07-28 Ptc Therapeutics Inc Metodos para tratar la enfermedad de huntington.
JP7399870B2 (ja) 2018-03-27 2023-12-18 ピーティーシー セラピューティクス， インコーポレイテッド ハンチントン病を処置するための化合物
DK3814357T3 (da) 2018-06-27 2024-07-22 Ptc Therapeutics Inc Heterocykliske og heteroarylforbindelser til behandling af huntingtons sygdom
EP3814360A1 (en) 2018-06-27 2021-05-05 PTC Therapeutics, Inc. Heteroaryl compounds for treating huntington's disease

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3072485A (en) * 1960-08-24 1963-01-08 Eastman Kodak Co Optically sensitized azido polymers for photomechanical resist compositions
AT299212B (de) * 1966-11-02 1972-06-12 Chinoin Gyogyszer Es Vegyeszet Verfahren zur Herstellung von neuen Homopyrimidazol-Derivaten sowie von deren Salzen
US3960847A (en) * 1972-04-17 1976-06-01 E. R. Squibb & Sons, Inc. 9-Substituted-4-oxopyrido(1,2-α)pyrimidine-3-carboxylic acids and derivatives thereof
US3929787A (en) * 1974-04-22 1975-12-30 Squibb & Sons Inc 6,7,8,9-Tetrahydro-pyrido(1,2-a)pyrimidin-4-ones
US3960863A (en) * 1974-06-25 1976-06-01 Sankyo Company Limited Pyrido[1,2-a]pyrimidinone derivatives
US4017625A (en) * 1975-08-01 1977-04-12 Pfizer Inc. Anti-allergic N-(5-tetrazolyl)-1-oxo-1H-6-alkoxypyrimido-[1,2-a]quinoline-2-carboxamides and intermediates therefor
US4012387A (en) * 1975-09-18 1977-03-15 Warner-Lambert Company Benzo-[g]pyrido[2,1-b]quinazolinones

Also Published As

Publication number Publication date
CY1218A (en) 1984-04-06
YU123678A (en) 1983-02-28
DK228878A (da) 1978-11-26
ZA782816B (en) 1979-05-30
FI64594B (fi) 1983-08-31
NO150361C (no) 1984-10-03
KE3357A (en) 1984-02-03
FR2401159A1 (fr) 1979-03-23
NO150361B (no) 1984-06-25
AT365187B (de) 1981-12-28
DK160279C (da) 1991-07-22
DK160279B (da) 1991-02-18
NL190702C (nl) 1994-07-01
CA1098520A (en) 1981-03-31
IT7849523A0 (it) 1978-05-24
US4122274A (en) 1978-10-24
IE781036L (en) 1978-11-25
CH642656A5 (de) 1984-04-30
HK25884A (en) 1984-03-30
GR71887B (nl) 1983-08-04
LU79694A1 (fr) 1979-02-02
FI781614A (fi) 1978-11-26
FI64594C (fi) 1983-12-12
DE2822544C2 (nl) 1988-10-27
AU521211B2 (en) 1982-03-25
AU3631978A (en) 1979-11-29
JPS6050197B2 (ja) 1985-11-07
YU44212B (en) 1990-04-30
IT1105040B (it) 1985-10-28
NL7805534A (nl) 1978-11-28
GB1596476A (en) 1981-08-26
IE46849B1 (en) 1983-10-05
SG73383G (en) 1984-08-03
DE2822544A1 (de) 1978-12-07
JPS5436294A (en) 1979-03-16
SE437830B (sv) 1985-03-18
ATA373278A (de) 1981-05-15
YU233082A (en) 1988-08-31
FR2401159B1 (nl) 1983-05-20
MY8500305A (en) 1985-12-31
YU42163B (en) 1988-06-30
BE867295A (fr) 1978-11-20
SE7805954L (sv) 1978-11-26
NO781786L (no) 1978-11-28

Similar Documents

Publication Publication Date Title
NL190702B (nl) 4h-pyrido(1,2-a)pyrimidin-4-on verbinding met anti-allergische werkzaamheid, alsmede farmaceutisch preparaat daarvan.
NL7805510A (nl) Farmaceutisch preparaat met vertraagde afgifte.
NO801863L (no) Farmasoeytiske preparater.
SE7810905L (sv) Nya 2,6-diaminonebularinderivat med farmaceutisk anvendning
IT1189229B (it) Polipeptedi,loro preparazione e loro impiego come medicamenti
NL189999C (nl) Farmaceutisch preparaat met werkzaamheid tegen tumoren.
NL185622C (nl) Farmaceutisch preparaat met antibacteriele werking, alsmede 7beta-acylamino-7alfa-methoxy-3-heterocyclylthiomethyl-3-cefem-4-carbonzuur.
NL7805588A (nl) 3,3,3-triarylalkyl-4-fenylalkyl-4-hydroxypiperidinen met geneeskrachtige activiteit.
TR20736A (tr) Flor-suebstitueye fenoksibenziloksikarbonil tuerevleri bunlarin,hazirlanisi icin usuller ve bunlarin ensektisidler ve akarisidler olarak kullanilmalari
NL7711446A (nl) Pharmaceutische desinfecterend preparaat.
NL192741B (nl) Oxazafosforin-4-thioalkaanzuurverbindingen en farmaceutisch preparaat met antineoplastische eigenschappen.
IT7821686A0 (it) Composizione farmaceutica.
IT7830474A0 (it) 1-n-aril-1,4-di-idro-piridine e il loro impiego come prodotti medicinali.
NL7806573A (nl) Preparaten met geneeskundige werkzaamheid.
NL7800169A (nl) Farmaceutische preparaten met anti-ulcuswerking in het maag-darmkanaal.
DE2862059D1 (en) Thiazolidinedione-2,4 derivatives, their preparation and pharmaceutical applications
TR19194A (tr) N-sulfenillenmis oksim-karbamatlar,bunlarin hazirlanisina ait usul ve bunlarin ensektisidler,akarisidler ve nematosidler olarak kullanilmalari
DE2860410D1 (en) 2-piperazinotetraline derivatives, their preparation and their use as medicines
NL7801921A (nl) Farmaceutische preparaten.
NL7804361A (nl) Leucinerijk 3,1-s-alpha2-glycoproteine, zijn berei- ding en toepassing.
NL7705561A (nl) Farmaceutisch preparaat en werkwijzen voor de bereiding en toepassing ervan.
NL7902993A (nl) Nieuwe isochinolinederivaten, de bereiding ervan en farmaceutische preparaten, die de nieuwe isochinoline- derivaten bevatten.
IT7829638A0 (it) 2,4-diammino-5-benzil-pirimidine eprocedimento per la loro preparazione.
NL7805158A (nl) Farmaceutisch preparaat.
NL190120B (nl) 2,3-dihydro-4h-1-benzopyran-4-on-0-carbamoyloximen alsmede farmaceutisch preparaat daarvan.

Legal Events

Date Code Title Description
BT A notification was added to the application dossier and made available to the public
A85 Still pending on 85-01-01
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
DNT Communications of changes of names of applicants whose applications have been laid open to public inspection

Free format text: BRISTOL-MYERS SQUIBB COMPANY

V4 Discontinued because of reaching the maximum lifetime of a patent

Free format text: 980522